Real-world evaluation of change in depressive symptoms among patients with treatment-resistant depression treated with esketamine
Among patients with TRD treated with esketamine in real-world settings, significant improvements in depressive symptoms were observed over the six months following treatment initiation.
Authors
- Carl D. Marci
- Manish K. Jha (ORCID: https://orcid.org/0000-0002-2764-2391)
- Janis L. Breeze (ORCID: https://orcid.org/0000-0002-5458-1010)
- Kruti Joshi (ORCID: https://orcid.org/0000-0001-9263-5158)
- Stevan G. Severtson
Institutions
- Southwestern Medical Center (US)
- Office of Multidisciplinary Activities (US)
- Janssen (United States) (US)
- Southwestern Medical Center (US)
- Janssen Scientific Affairs (United States)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1186/s12888-025-07485-w
- Citations
- 2
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 2.79